nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroxoline—METAP2—uterine cervix—vaginal cancer	0.151	0.151	CbGeAlD
Nitroxoline—METAP2—urethra—vaginal cancer	0.138	0.138	CbGeAlD
Nitroxoline—METAP2—endometrium—vaginal cancer	0.136	0.136	CbGeAlD
Nitroxoline—METAP2—mammalian vulva—vaginal cancer	0.132	0.132	CbGeAlD
Nitroxoline—METAP2—uterus—vaginal cancer	0.126	0.126	CbGeAlD
Nitroxoline—METAP2—female reproductive system—vaginal cancer	0.113	0.113	CbGeAlD
Nitroxoline—METAP2—female gonad—vaginal cancer	0.103	0.103	CbGeAlD
Nitroxoline—METAP2—vagina—vaginal cancer	0.102	0.102	CbGeAlD
